本文对166例乙型脑炎患者随机分组治疗,结果表明,免疫促进疗法组(正常人转移因子和免疫核糖核酸)的重型患者的病死率(16.3％)比常规治疗组(中西医综合治疗合并皮质激素)的病死率(38.9％)显著为低;此外,对退热、气管切开与自主呼吸停止者的治疗效果,亦以免疫促进疗法组为优。由此初步认为皮质激素对乙型脑炎无常规应用之必要;而对合并中枢性呼吸衰竭者,联合应用免疫促进剂和皮质激素可获较好的效果。 In this paper, 166 patients with Japanese encephalitis were randomized into groups. The results showed that the case fatality rate (16.3%) of the patients in the immunosuppressive therapy group (normal human transfer factor and immune ribonucleic acid) was significantly lower than that of the conventional treatment group Corticosteroids) was significantly lower (38.9%); in addition, the treatment of fever, tracheostomy and spontaneous respiratory arrest were also superior to the immunosuppressive therapy group. This preliminary view that corticosteroids have no conventional application of Japanese encephalitis is necessary; and for those with central respiratory failure, the combination of immunosuppressive agents and corticosteroids can be better results.